Education
About Us
Working with TipRanks
Follow Us
Outset Medical, Inc. (OM)
:OM
OM Stock Chart & Stats
$15.53
-$0.10(-9.09%)
At close: 4:00 PM EST
$15.53
-$0.10(-9.09%)
Day’s Range― - ―
52-Week Range$5.85 - $25.35
Previous CloseN/A
Volume1.92M
Average Volume (3M)259.18K
Market Cap
$209.57M
Enterprise Value$259.02M
Total Cash (Recent Filing)$184.09M
Total Debt (Recent Filing)$3.62M
Price to Earnings (P/E)―
Beta1.62
Next Earnings
Nov 10, 2025EPS Estimate
-0.66Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.84
Shares Outstanding17,766,193
10 Day Avg. Volume155,466
30 Day Avg. Volume259,183
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)2.15
Price to Sales (P/S)0.51
P/FCF Ratio-0.49
Enterprise Value/Market Cap1.24
Enterprise Value/Revenue2.17
Enterprise Value/Gross Profit5.95
Enterprise Value/Ebitda-3.42
Forecast
1Y Price Target
$17.00Price Target Upside9.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-4.31
Revenue Forecast (FY)$124.03M
Bulls Say, Bears Say
Bulls Say
Clinical And Financial ImprovementsThe nurse leader emphasized the significant positive clinical, operational, and financial improvements realized with Tablo, driving broad adoption across hospitals.
Cost EfficiencyTablo treatments are roughly half the cost of prior outsourced dialysis treatments, contributing to a 20%-40% annual return on investment for converted hospitals.
Technological InnovationThe Tablo hemodialysis system is seen as having game-changing technology potential with ongoing opportunities for broad US adoption.
Bears Say
Outset Medical News
OM FAQ
What was Outset Medical, Inc.’s price range in the past 12 months?
Outset Medical, Inc. lowest stock price was $5.85 and its highest was $25.35 in the past 12 months.
What is Outset Medical, Inc.’s market cap?
Outset Medical, Inc.’s market cap is $209.57M.
When is Outset Medical, Inc.’s upcoming earnings report date?
Outset Medical, Inc.’s upcoming earnings report date is Nov 10, 2025 which is tomorrow.
How were Outset Medical, Inc.’s earnings last quarter?
Outset Medical, Inc. released its earnings results on Aug 06, 2025. The company reported -$0.84 earnings per share for the quarter, beating the consensus estimate of -$0.982 by $0.142.
Is Outset Medical, Inc. overvalued?
According to Wall Street analysts Outset Medical, Inc.’s price is currently Undervalued.
Does Outset Medical, Inc. pay dividends?
Outset Medical, Inc. does not currently pay dividends.
What is Outset Medical, Inc.’s EPS estimate?
Outset Medical, Inc.’s EPS estimate is -0.66.
How many shares outstanding does Outset Medical, Inc. have?
Outset Medical, Inc. has 17,766,193 shares outstanding.
What happened to Outset Medical, Inc.’s price movement after its last earnings report?
Outset Medical, Inc. reported an EPS of -$0.84 in its last earnings report, beating expectations of -$0.982. Following the earnings report the stock price went up 7.669%.
Which hedge fund is a major shareholder of Outset Medical, Inc.?
Currently, no hedge funds are holding shares in OM
Outset Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.00 (9.47% Upside)
$17.00 (9.47% Upside)
Blogger Sentiment
Bullish
OM Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $19.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
3.59%
12-Months-Change
Fundamentals
Return on Equity
-87.65%
Trailing 12-Months
Asset Growth
-8.18%
Trailing 12-Months
Company Description
Outset Medical, Inc.
Outset Medical (OM) is a medical technology company focused on transforming the way dialysis is delivered to patients. The company operates within the healthcare sector, specifically targeting renal care, with a core product offering of the Tablo Hemodialysis System. This innovative system simplifies the dialysis process for both patients and healthcare providers, enabling efficient treatment in various settings, including in-home and clinic environments.
OM Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with significant revenue growth, increased guidance, and strong performance in console and recurring revenue. The company's strategic agreements and improvements in gross margin and operating expenses underscore positive momentum. Despite minor challenges with manufacturing overhead absorption and service gross margin, the company's outlook remains optimistic.View all OM earnings summariesOM Revenue Breakdown
47.04% Consoles
32.37% Consumables
20.59% Service and other revenue
OM Stock 12 Month Forecast
Average Price Target
$17.00
▲(9.47% Upside)
Technical Analysis
Ownership Overview
4.16% Insiders
30.56% Mutual Funds
2.12% Other Institutional Investors
54.32% Public Companies and
Individual Investors